Ms. Portale joined Poseida as vice president of regulatory affairs in April 2019. She has more than 25 years of regulatory experience, integrating regulatory strategy into drug development and precision medicine across multiple therapeutic areas. She joins Poseida from Pfizer, where she was the global regulatory portfolio leader for oncology overseeing over 20 development programs. Prior to joining Pfizer, Lisa served as a regulatory affairs leader for Phenomix, Neurocrine Biosciences, Medtronic and Warner Lambert/Parke Davis. Her regulatory experience spans oncology/immuno-oncology, cardiovascular, endocrinology, neuroscience and combination products. This includes the development of novel biological structures including ADCs, bi-specifics, CAR-Ts, nanoparticles, therapeutic/oncolytic vaccines and traditional monoclonal antibodies. Lisa received her B.S. in biological sciences from Michigan State University and also obtained RAC certification.